Jeremy G Chadwick - Net Worth and Insider Trading

Jeremy G Chadwick Net Worth

The estimated net worth of Jeremy G Chadwick is at least $2 Million dollars as of 2024-11-05. Jeremy G Chadwick is the COO of Kymera Therapeutics Inc and owns about 44,183 shares of Kymera Therapeutics Inc (KYMR) stock worth over $2 Million. Details can be seen in Jeremy G Chadwick's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeremy G Chadwick has not made any transactions after 2024-05-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jeremy G Chadwick

To

Jeremy G Chadwick Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeremy G Chadwick owns 2 companies in total, including Madrigal Pharmaceuticals Inc (MDGL) , and Kymera Therapeutics Inc (KYMR) .

Click here to see the complete history of Jeremy G Chadwick’s form 4 insider trades.

Insider Ownership Summary of Jeremy G Chadwick

Ticker Comapny Transaction Date Type of Owner
MDGL Madrigal Pharmaceuticals Inc 2007-02-05 Sr. VP & Program Mgmt and Ops
KYMR Kymera Therapeutics Inc 2024-05-23 Chief Operating Officer

Jeremy G Chadwick Latest Holdings Summary

Jeremy G Chadwick currently owns a total of 1 stock. Jeremy G Chadwick owns 44,183 shares of Kymera Therapeutics Inc (KYMR) as of May 23, 2024, with a value of $2 Million.

Latest Holdings of Jeremy G Chadwick

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KYMR Kymera Therapeutics Inc 2024-05-23 44,183 47.17 2,084,112

Holding Weightings of Jeremy G Chadwick


Jeremy G Chadwick Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeremy G Chadwick has made a total of 1 transactions in Kymera Therapeutics Inc (KYMR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kymera Therapeutics Inc is the sale of 2,575 shares on May 23, 2024, which brought Jeremy G Chadwick around $90,099.

Insider Trading History of Jeremy G Chadwick

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeremy G Chadwick Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeremy G Chadwick Ownership Network

Ownership Network List of Jeremy G Chadwick

No Data

Ownership Network Relation of Jeremy G Chadwick

Insider Network Chart

Jeremy G Chadwick Owned Company Details

What does Madrigal Pharmaceuticals Inc do?

Who are the key executives at Madrigal Pharmaceuticals Inc?

Jeremy G Chadwick is the Sr. VP & Program Mgmt and Ops of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & President and CEO William John Sibold , Senior VP & Chief Pharma Dev. Robert E. Waltermire , and director & 10 percent owner Fred B Craves .

Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary

Over the past 18 months, Jeremy G Chadwick made no insider transaction in Madrigal Pharmaceuticals Inc (MDGL). Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 12,736 shares made by Robert E. Waltermire , and a net sale of 100,000 shares made by Paul A Friedman .

In summary, during the past 3 months, insiders sold 6,363 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 6,363 shares. During the past 18 months, 303,930 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 120,755 shares.

Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Madrigal Pharmaceuticals Inc Insider Transactions

No Available Data

Jeremy G Chadwick Mailing Address

Above is the net worth, insider trading, and ownership report for Jeremy G Chadwick. You might contact Jeremy G Chadwick via mailing address: C/o Kymera Therapeutics, Inc., 200 Arsenal Yards Blvd., Suite 230, Watertown Ma 02472.